Panel discussion on Italian Pharma Outlook

In this news, we present a Panel Discussion on the Italian Pharma outlook, taking into account different segments of the market, from APIs to Biosimilars and discuss future potential for bringing increasing investment and innovation in the long-term.Representatives from the 3 most important Italian associations – Aschimfarma, Assogenerici, Farmindustria, and experts from a few companies belonging to these associations - have been invited to participate around a virtual table and discuss in particular about market demands; economic accessibility, sustainability and security of the supply chain; innovation; the need for a crisis-resistant system within EU. Among the panelists is also Daniele Giavini, Indena Managing Director, talking about the company’s target markets, innovation and technology.